Flexion Therapeutics Stumbles on Clinical Hold
In the after-hours on Wednesday, Flexion Therapeutics made a hard fall on the news of a clinical hold.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 283Analyst Sees Incyte Worth 70% More
Incyte has serious upside potential, but the inherent risk within it may be too much for some investors to bear.
Why Endo Wants to Acquire Auxilium So Much
Endo International made an unsolicited buyout offer to Auxilium Pharmaceuticals, right after the latter announced that it had entered into an agreement to merge with QLT.
Is Avanir Pharma Fully Valued After Monday’s Rally?
Avanir Pharmaceuticals posted amazing gains on Monday following the announcement of a successful Phase 1 trial, but is it now fully valued?
ReWalk Goes From Marching to Sprinting
Shares of Rewalk Robotics surged again on Monday, following its initial public offering on Friday.
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
A new research report from UBS focuses on four top companies that are making great strides in treatments for patients -- and generating gigantic revenues.
Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs
Avanir Pharmaceuticals announced positive Phase 2 results for its drug candidate AVP-923, a potential new therapy for patients with Alzheimer’s disease.
NPS Pharma Enters Cautionary Phase of the FDA Approval Process
NPS Pharmaceuticals traded lower on what sounded like good news. The problem is that headlines often do not reveal the true underlying story.
Deep Discount for Health Care REIT Secondary Offering
Health Care REIT has joined the waves of companies looking to raise capital after strong share price gains.
Short Sellers Remain Vigilant Against Biotechs
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest report.
Virobay Files For Initial Public Offering
ThinkstockVirobay, Inc. has filed with the Securities and Exchange Commission for an initial public offering. There were no terms given for the offering but the filing is for up to $50 million in common. The company…
Does New Data Make or Break NPS Pharmaceuticals?
ThinkstockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical trial. The FDA has posted the briefing materials prior to the meeting for approval.…
IPO Filing: Xenon Pharmaceuticals
Xenon Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act
While not flashy or super high-profile, these health care companies are expected to deliver solid earnings growth for the foreseeable future.
IPO Filing: PRA Health Sciences — from KKR
PRA Health Sciences has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.